A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)

NCT02759107 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: Tirzepatide
DRUG: Placebo
DRUG: Dulaglutide

Sponsor

Eli Lilly and Company